Bloom syndrome protein (BLM) regulates the activation of the MAPK/ERK signaling pathway by interacting with hepatoma-derived growth factor (HDGF), inducing KRAS expression and RhoA inhibition to promote the malignant progression of PCa.39 The gene discussed is BLM; the disease is posterior cortical atrophy.